How much does a box of mirikizumab cost? Market reference

Milikizumab (Mirikizumab), as an innovative biological agent targeting IL-23 recently approved overseas, is widely used in patients with moderate to severe ulcerative colitis and is gradually showing potential in Crohn's disease research. As the popularity of drugs in the global field of inflammatory bowel disease continues to rise, their prices, usage scenarios and long-term treatment models have become one of the most frequently asked questions by patients. Since the original drug has not yet been officially launched in China and its domestic price has not yet been announced, many patients can only rely on overseas prices for reference.

Milizumab is currently sold overseas in injection form, with a common specification of 300mg/15mL per vial. Because it is a biological antibody drug with high production costs, long research and development cycles, and market competition is still in its early stages, the pricing in most countries is generally high. According to public quotations from medical institutions and commercial pharmacies, the price of a single box is usually more than 10,000 yuan, and will fluctuate due to exchange rate changes, import channels, and differences in national medical insurance policies. Considering that it is a newly launched drug and there are currently no generic drugs in the world, the market price is mostly based on the original research price.

In terms of application, militizumab is mainly used for patients with ulcerative colitis who have poor response to traditional treatments, have significant fluctuations in moderate to severe symptoms, or who need to reduce the risk of recurrence. It gradually stabilizes inflammation by inhibiting IL-23 activity. Many patients gradually improve symptoms such as abdominal pain, frequent bowel movements, and bleeding after using it for a period of time. For people suffering from chronic inflammation, militizumab can help restore the intestinal mucosa, improve quality of life, improve dietary absorption, and reduce fatigue.

In the treatment cycle, its usage is usually divided into induction phase and maintenance phase. The induction phase is mainly used to quickly reduce inflammatory activity, while the maintenance phase ensures stable disease and reduces recurrence and repeated fluctuations in the course of the disease. Because biologics often require long-term treatment, patients need to consider the overall cost of treatment when evaluating price, not just the price of a single box.

Reference materials:https://omvoh.lilly.com/